[1] Sethuraman VK, Viswanathan S, Aghoram R. Refractory Hypoglycemia and Seizures as the Initial Presenting Manifestation of Empty Sella Syndrome. Cureus. 2018; 10(6):e2803. doi: 10.7759/cureus.2803.
[2] Arzamendi AE, Shahlaie K, Latchaw RE, Lechpammer M, Arzumanyan H. Ectopic Acromegaly Arising from a Pituitary Adenoma within the Bony Intersphenoid Septum of a Patient with Empty Sella Syndrome. J Neurol Surg Rep. 2016; 77(3):e113-7. doi: 10.1055/s-0036-1585091.
[3] Auer MK, Stieg MR, Crispin A, Sievers C, Stalla GK, Kopczak A. Primary Empty Sella Syndrome and the Prevalence of Hormonal Dysregulation. Dtsch Arztebl Int. 2018; 115(7):99-105. doi: 10.3238/arztebl.2018.0099.
[4] Debnath J, Ravikumar R, Sharma V, Senger KP, Maurya V, Singh G, et al. 'Empty sella' on routine MRI studies: an incidental finding or otherwise? Med J Armed Forces India. 2016; 72:33–37. doi: 10.1016/j.mjafi.2015.11.012.
[5] Fan X, Liu Z, Fu S, Sang J, Deng H, Li F, et al. Platelet Distribution Width at First Day of Hospital Admission in Patients with Hemorrhagic Fever with Renal Syndrome Caused by Hantaan Virus May Predict Disease Severity and Critical Patients' Survival. Dis Markers. 2018; 2018:9701619. doi: 10.1155/2018/9701619.
[6] Wu H, Wang X, Xue M, Wu C, Lu Q, Ding Z, et al. Spatial-temporal characteristics and the epidemiology of haemorrhagic fever with renal syndrome from 2007 to 2016 in Zhejiang Province, China. Sci Rep. 2018; 8(1):10244. doi: 10.1038/s41598-018-28610-8.
[7] Jiang H, Du H, Wang LM, Wang PZ, Bai XF. Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture. Front Cell Infect Microbiol. 2016; 6:1. doi: 10.3389/fcimb.2016.00001.
[8] Tang JH, Gao DP, Zou PF. Comparison of serum PCT and CRP levels in patients infected by different pathogenic microorganisms: a systematic review and meta-analysis. Braz J Med Biol Res. 2018; 51(7):e6783. doi: 10.1590/1414-431x20176783.
[9] Pal E, Korva M, Resman Rus K, Kejžar N, Bogovič P, Kurent A, et al. Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome. PLoS One. 2018; 13(5):e0197661. doi: 10.1371/journal.pone.0197661.
[10] Yu Z, Zhou N, Li A, Chen J, Chen H, He Z, et al. Performance assessment of the SAPS II and SOFA scoring systems in Hanta virus Hemorrhagic Fever with Renal Syndrome. Int J Infect Dis. 2017; 63:88-94. doi: 10.1016/j.ijid.2017.08.003.
[11] Fan X, Deng H, Sang J, Li N, Zhang X, Han Q, et al. High Serum Procalcitonin Concentrations in Patients With Hemorrhagic Fever With Renal Syndrome Caused by Hantaan Virus. Front Cell Infect Microbiol. 2018; 8:129. doi: 10.3389/fcimb.2018.00129.
[12] Latus J, Schwab M, Tacconelli E, Pieper FM, Wegener D, Dippon J, et al. Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany. Emerg Infect Dis. 2015; 21(1):76-83. doi: 10.3201/eid2101.140861.
[13] Moreli ML, Marques-Silva AC, Pimentel VA, da Costa VG. Effectiveness of the ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis. Virusdisease. 2014; 25(3):385-9. doi: 10.1007/s13337-014-0219-7.
[14] De Marinis L, Bonadonna S, Bianchi A, Maira G, Giustina A. Primary empty sella. J Clin Endocrinol Metab. 2005; 90(9):5471-7.
[15] Ahn HJ, Chung JH, Kim DM, Yoon NR, Kim CM. Hemorrhagic fever with renal syndrome accompanied by panhypopituitarism and central diabetes insipidus: a case report. J Neurovirol. 2018; 24(3):382-387. doi: 10.1007/s13365-018-0624-6.
[16] Pekic S, Cvijovic G, Stojanovic M, Kendereski A, Micic D, Popovic V. Hypopituitarism as a late complication of hemorrhagic fever. Endocrine. 2005; 26(2):79-82.
[17] Stojanovic M, Pekic S, Cvijovic G, Miljic D, Doknic M, Nikolic-Djurovic M, et al. High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J Clin Endocrinol Metab. 2008; 93(7):2722-8. doi: 10.1210/jc.2008-0311.
[18] Brownlee S, Chalkidou K, Doust J, Elshaug AG, Glasziou P, Heath I, et al. Evidence for overuse of medical services around the world. Lancet. 2017;390:156–168. doi: 10.1016/S0140-6736(16)32585-5.
[19] Webb SM, Crespo I, Santos A, Resmini E, Aulinas A, Valassi E. Management of endocrine disease: quality of life tools for the management of pituitary disease. Eur J Endocrinol. 2017; 177:R13–R26. doi: 10.1530/EJE-17-0041.